瑞普生物 - Financials

瑞普生物 — Financial Statements

Annual Quarterly

5 10 All

Income Statement

Balance Sheet

Cash Flow

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013	FY 2012Dec 31, 2012	FY 2011Dec 31, 2011	FY 2010Dec 31, 2010	FY 2009Dec 31, 2009	FY 2008Dec 31, 2008	FY 2007Dec 31, 2007
+Revenue	3.1B	2.7B	2.1B	2.0B	2.0B	1.5B	1.2B	1.0B	970.0M	793.0M	585.0M	755.0M	656.0M	588.0M	346.0M	285.0M	224.0M	146.0M
Revenue Growth %	13.3%	30.0%	3.8%	0.4%	36.3%	23.3%	13.7%	7.9%	22.3%	35.6%	-22.5%	15.1%	11.6%	69.9%	21.4%	27.2%	53.4%	--
Total Revenue	3.1B	2.7B	2.1B	2.0B	2.0B	1.5B	1.2B	1.0B	970.0M	793.0M	585.0M	755.0M	656.0M	588.0M	346.0M	285.0M	224.0M	146.0M
Cost Of Revenue	1.8B	1.5B	1.1B	967.0M	919.0M	699.0M	594.0M	492.0M	414.0M	327.0M	237.0M	307.0M	273.0M	260.0M	101.0M	64.8M	59.0M	47.5M
+Gross Profit	1.3B	1.2B	1.0B	1.0B	1.1B	768.0M	596.0M	555.0M	556.0M	466.0M	348.0M	448.0M	383.0M	328.0M	245.0M	220.2M	165.0M	98.5M
Gross Margin %	41.4%	43.6%	48.4%	51.8%	54.0%	52.4%	50.1%	53.0%	57.3%	58.8%	59.5%	59.3%	58.4%	55.8%	70.8%	77.3%	73.7%	67.5%
Total Operating Cost	2.7B	2.4B	1.8B	1.7B	1.6B	1.3B	1.1B	953.0M	827.0M	671.0M	565.0M	604.0M	498.0M	445.0M	241.0M	185.0M	152.0M	91.3M
Selling Expenses	451.0M	410.0M	344.0M	379.0M	356.0M	279.0M	232.0M	216.0M	200.0M	202.0M	226.0M	190.0M	137.0M	139.0M	100.0M	93.4M	73.9M	31.6M
Admin Expenses	189.0M	174.0M	143.0M	150.0M	165.0M	141.0M	110.0M	103.0M	176.0M	130.0M	103.0M	105.0M	98.5M	62.4M	38.5M	24.8M	17.9M	11.1M
Rd Expenses	197.0M	173.0M	133.0M	118.0M	112.0M	94.8M	80.3M	85.3M	--	--	--	--	--	--	--	--	--	--
Finance Expenses	27.2M	20.5M	17.3M	18.8M	25.6M	23.2M	15.6M	14.6M	8.9M	-858,300	-7.4M	-14.7M	-21.5M	-24.7M	-1.9M	-500,100	-78,700	132,900
+Operating Income	373.0M	570.0M	417.0M	499.0M	513.0M	263.0M	162.0M	142.0M	150.0M	125.0M	20.6M	151.0M	159.0M	144.0M	104.0M	99.9M	72.2M	54.8M
Operating Margin %	12.1%	21.0%	20.0%	24.9%	25.7%	17.9%	13.6%	13.6%	15.5%	15.8%	3.5%	20.0%	24.2%	24.5%	30.1%	35.0%	32.2%	37.5%
Non Operating Income	1.6M	3.0M	3.4M	3.0M	918,600	1.9M	1.4M	3.4M	31.7M	17.6M	19.0M	29.0M	19.3M	6.8M	15.4M	3.0M	3.3M	2.1M
Non Operating Expenses	6.5M	1.6M	6.3M	14.6M	3.1M	5.1M	1.2M	987,200	2.7M	1.4M	439,100	751,200	815,300	667,100	114,500	1.5M	71,800	53,900
Investment Income	9.1M	15.2M	4.1M	18.5M	1.5M	15.0M	13.4M	15.7M	7.2M	3.9M	-76,200	-335,500	1.1M	1.2M	-1.2M	-19,200	283,900	--
Fair Value Change Income	-10.7M	61.3M	51.4M	114.0M	117.0M	68.2M	--	--	--	--	--	--	--	--	--	--	--	--
Asset Disposal Income	-16,700	114.0M	-7,000	98,200	-18,200	4,400	--	--	--	--	--	--	--	--	--	--	--	--
Asset Impairment Loss	19.8M	-580,200	-473,500	852,600	817,900	10.4M	18.2M	25.3M	16.7M	8.8M	2.9M	10.6M	5.6M	4.1M	1.7M	1.8M	1.1M	1.0M
Other Income	34.3M	28.5M	27.2M	33.1M	22.1M	23.2M	24.4M	31.9M	--	--	--	--	--	--	--	--	--	--
Income Before Tax	368.0M	571.0M	414.0M	488.0M	511.0M	260.0M	162.0M	144.0M	178.0M	142.0M	39.1M	179.0M	178.0M	150.0M	119.0M	101.0M	75.4M	56.8M
Income Tax	38.5M	56.2M	40.0M	54.2M	71.4M	36.1M	20.9M	19.7M	25.2M	19.1M	10.4M	25.7M	26.2M	21.6M	18.7M	13.0M	9.7M	1.5M
+Net Income	330.0M	515.0M	374.0M	434.0M	439.0M	224.0M	141.0M	125.0M	153.0M	122.0M	28.7M	153.0M	152.0M	128.0M	100.0M	88.3M	65.7M	55.3M
Net Margin %	10.7%	19.0%	17.9%	21.6%	21.9%	15.3%	11.8%	11.9%	15.8%	15.4%	4.9%	20.3%	23.2%	21.8%	28.9%	31.0%	29.3%	37.9%
Net Income Attributable	301.0M	454.0M	347.0M	413.0M	398.0M	194.0M	119.0M	105.0M	133.0M	110.0M	27.0M	152.0M	144.0M	114.0M	82.5M	61.5M	43.3M	37.0M
Minority Interest	29.1M	61.4M	27.1M	20.8M	41.3M	29.4M	22.1M	19.9M	20.5M	12.2M	1.7M	1.3M	7.5M	14.1M	17.9M	26.8M	22.4M	18.3M
Eps Basic	0.65	0.98	0.75	1.03	1.01	0.49	0.29	0.26	0.34	0.28	0.07	0.39	0.75	0.59	0.69	1.10	0.82	0.84
Eps Diluted	0.65	0.98	0.75	1.03	1.01	0.49	0.29	0.26	0.34	0.28	0.07	0.39	0.75	0.59	0.69	1.10	0.82	0.84

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013	FY 2012Dec 31, 2012	FY 2011Dec 31, 2011	FY 2010Dec 31, 2010	FY 2009Dec 31, 2009	FY 2008Dec 31, 2008	FY 2007Dec 31, 2007
Cash And Equivalents	487.0M	339.0M	384.0M	1.3B	294.0M	396.0M	288.0M	398.0M	295.0M	268.0M	414.0M	511.0M	702.0M	897.0M	1.2B	118.0M	115.0M	47.4M
Trading Financial Assets	1.5B	1.3B	1.5B	578.0M	400.0M	385.0M	--	--	--	--	--	--	--	--	--	--	--	--
Accounts Receivable	1.0B	987.0M	743.0M	573.0M	443.0M	348.0M	381.0M	344.0M	308.0M	296.0M	271.0M	325.0M	193.0M	102.0M	80.8M	72.0M	49.5M	34.1M
Notes Receivable	30.4M	12.8M	4.0M	33.6M	22.4M	1.2M	18.7M	7.4M	4.5M	6.3M	6.6M	5.6M	2.3M	2.0M	811,600	3.1M	1.2M	1.3M
Notes And Accounts Receivable	1.1B	1.0B	747.0M	606.0M	465.0M	349.0M	400.0M	351.0M	313.0M	302.0M	278.0M	331.0M	195.0M	104.0M	81.6M	75.2M	50.8M	35.4M
Prepayments	61.2M	64.3M	21.6M	35.3M	28.6M	59.7M	80.5M	90.4M	41.6M	34.4M	26.4M	40.3M	58.6M	159.0M	28.6M	18.6M	13.4M	8.3M
Inventory	500.0M	497.0M	367.0M	360.0M	364.0M	264.0M	258.0M	237.0M	219.0M	182.0M	143.0M	114.0M	126.0M	112.0M	65.1M	37.3M	24.0M	18.8M
Total Current Assets	3.6B	3.5B	3.1B	3.1B	1.6B	1.5B	1.4B	1.3B	1.2B	901.0M	907.0M	1.1B	1.1B	1.3B	1.4B	255.0M	209.0M	116.0M
Long Term Equity Investment	1.1B	453.0M	377.0M	275.0M	223.0M	222.0M	86.8M	86.5M	89.8M	90.6M	4.1M	3.1M	11.3M	20.4M	38.6M	16.1M	6.2M	--
Fixed Assets	--	1.5B	1.2B	799.0M	735.0M	772.0M	807.0M	835.0M	855.0M	619.0M	338.0M	312.0M	325.0M	212.0M	138.0M	92.6M	95.5M	47.9M
Fixed Assets Total	1.8B	1.5B	1.2B	799.0M	735.0M	772.0M	807.0M	835.0M	855.0M	619.0M	338.0M	312.0M	325.0M	212.0M	138.0M	92.6M	95.5M	47.9M
Construction In Progress	--	87.8M	374.0M	379.0M	380.0M	261.0M	147.0M	93.9M	80.3M	302.0M	465.0M	376.0M	116.0M	8.7M	43.1M	22.7M	123,100	7.9M
Construction In Progress Total	62.7M	87.8M	374.0M	379.0M	380.0M	261.0M	147.0M	93.9M	80.3M	302.0M	465.0M	376.0M	116.0M	8.7M	43.1M	22.7M	123,100	7.9M
Intangible Assets	493.0M	238.0M	259.0M	246.0M	249.0M	251.0M	231.0M	238.0M	241.0M	229.0M	171.0M	164.0M	146.0M	97.1M	32.8M	27.1M	24.2M	13.9M
Long Term Deferred Expenses	944,100	1.3M	885,400	1.2M	885,500	767,200	2.0M	2.7M	3.7M	4.6M	--	167,700	303,300	--	--	--	--	37,300
Total Non Current Assets	4.3B	3.5B	3.0B	2.6B	2.3B	2.0B	1.6B	1.6B	1.6B	1.4B	1.1B	927.0M	647.0M	362.0M	254.0M	160.0M	127.0M	70.0M
Total Assets	8.0B	7.0B	6.1B	5.7B	3.9B	3.6B	3.0B	2.9B	2.7B	2.3B	2.0B	2.0B	1.8B	1.7B	1.6B	415.0M	335.0M	186.0M
Short Term Borrowings	801.0M	551.0M	667.0M	591.0M	402.0M	601.0M	351.0M	379.0M	240.0M	127.0M	25.0M	23.0M	31.0M	35.0M	78.0M	35.0M	10.0M	7.0M
Accounts Payable	363.0M	410.0M	329.0M	221.0M	188.0M	157.0M	144.0M	138.0M	142.0M	143.0M	78.3M	81.5M	76.9M	66.2M	48.0M	31.7M	16.4M	7.0M
Advance Receipts	8.3M	7.1M	73,600	120,300	572,300	26.4M	26.1M	26.7M	32.7M	27.2M	25.2M	13.8M	8.7M	14.1M	11.2M	9.0M	20.1M	3.0M
Contract Liabilities	48.1M	16.5M	22.3M	33.9M	27.2M	--	--	--	--	--	--	--	--	--	--	--	--	--
Total Current Liabilities	2.3B	1.6B	1.3B	1.1B	877.0M	1.0B	665.0M	657.0M	518.0M	495.0M	189.0M	221.0M	153.0M	153.0M	184.0M	150.0M	72.4M	39.5M
Long Term Borrowings	514.0M	307.0M	191.0M	90.1M	98.1M	--	--	9.2M	15.4M	--	--	--	--	--	--	--	--	--
Total Non Current Liabilities	708.0M	452.0M	295.0M	243.0M	285.0M	160.0M	78.6M	90.7M	110.0M	84.4M	70.1M	67.7M	53.5M	21.9M	11.8M	12.3M	12.8M	10.8M
Total Liabilities	3.0B	2.0B	1.6B	1.4B	1.2B	1.2B	744.0M	748.0M	628.0M	580.0M	259.0M	289.0M	207.0M	175.0M	196.0M	163.0M	85.2M	50.3M
Paid In Capital	466.0M	466.0M	468.0M	468.0M	404.0M	404.0M	404.0M	404.0M	404.0M	389.0M	389.0M	194.0M	193.0M	148.0M	74.1M	55.5M	55.5M	50.5M
Capital Reserve	2.2B	2.3B	2.2B	2.2B	963.0M	943.0M	948.0M	948.0M	944.0M	738.0M	820.0M	996.0M	974.0M	1.0B	1.1B	55.4M	57.6M	6.6M
Surplus Reserve	233.0M	232.0M	196.0M	172.0M	140.0M	111.0M	81.1M	72.3M	62.3M	54.4M	48.0M	43.5M	33.2M	25.2M	13.9M	5.8M	--	147,900
Retained Earnings	1.8B	1.7B	1.4B	1.2B	1.0B	747.0M	577.0M	527.0M	493.0M	426.0M	361.0M	378.0M	284.0M	193.0M	164.0M	89.7M	84.1M	42.1M
Minority Equity	537.0M	418.0M	280.0M	291.0M	281.0M	235.0M	244.0M	224.0M	202.0M	161.0M	112.0M	109.0M	102.0M	103.0M	73.6M	46.1M	52.7M	36.9M
Equity Attributable	4.5B	4.6B	4.2B	4.0B	2.5B	2.1B	2.0B	2.0B	1.9B	1.6B	1.6B	1.6B	1.5B	1.4B	1.4B	206.0M	197.0M	99.3M
Total Equity	5.0B	5.0B	4.5B	4.3B	2.7B	2.4B	2.3B	2.2B	2.1B	1.8B	1.7B	1.7B	1.6B	1.5B	1.4B	252.0M	250.0M	136.0M

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013	FY 2012Dec 31, 2012	FY 2011Dec 31, 2011	FY 2010Dec 31, 2010	FY 2009Dec 31, 2009	FY 2008Dec 31, 2008	FY 2007Dec 31, 2007
Cash From Sales	3.2B	2.6B	2.0B	2.0B	1.9B	1.5B	1.2B	1.0B	990.0M	806.0M	651.0M	631.0M	572.0M	584.0M	368.0M	260.0M	247.0M	145.0M
Tax Refunds Received	3.6M	5.2M	12.3M	14.9M	8.1M	749,200	280,800	591,900	1.4M	896,100	956,700	1.1M	1.9M	1.8M	286,500	--	3.7M	--
Total Operating Cash Inflow	4.1B	2.9B	2.0B	2.0B	2.0B	1.6B	1.2B	1.1B	1.0B	847.0M	744.0M	691.0M	643.0M	623.0M	408.0M	276.0M	290.0M	171.0M
Cash Paid For Goods	1.6B	1.4B	859.0M	846.0M	910.0M	611.0M	482.0M	411.0M	365.0M	237.0M	208.0M	234.0M	237.0M	236.0M	99.3M	66.0M	59.1M	64.3M
Cash Paid To Employees	499.0M	454.0M	371.0M	361.0M	294.0M	234.0M	193.0M	159.0M	142.0M	118.0M	116.0M	107.0M	87.8M	67.0M	35.2M	22.6M	21.1M	12.4M
Taxes Paid	163.0M	158.0M	100.0M	124.0M	121.0M	101.0M	83.9M	82.0M	82.3M	54.9M	63.1M	77.2M	62.5M	52.8M	41.2M	28.2M	34.3M	12.2M
Total Operating Cash Outflow	3.4B	2.5B	1.6B	1.7B	1.7B	1.2B	1.1B	960.0M	830.0M	622.0M	614.0M	602.0M	553.0M	532.0M	295.0M	212.0M	222.0M	151.0M
Operating Cash Flow	736.0M	410.0M	389.0M	383.0M	388.0M	384.0M	175.0M	110.0M	208.0M	225.0M	130.0M	88.7M	89.9M	90.3M	113.0M	64.6M	68.1M	19.1M
Total Investing Cash Inflow	3.5B	3.8B	2.5B	916.0M	929.0M	1.2B	1.7B	1.7B	555.0M	495.0M	100.0M	531,000	40,100	4,000	1,538	36,800	90,500	17.5M
Total Investing Cash Outflow	4.0B	4.1B	3.8B	1.5B	1.2B	1.6B	1.8B	1.8B	1.0B	1.0B	204.0M	355.0M	257.0M	203.0M	121.0M	35.9M	52.4M	34.4M
Investing Cash Flow	-452.0M	-301.0M	-1.2B	-627.0M	-243.0M	-398.0M	-145.0M	-58.3M	-450.0M	-552.0M	-104.0M	-354.0M	-257.0M	-203.0M	-121.0M	-35.8M	-52.3M	-16.9M
Cash From Borrowings	1.0B	728.0M	1.0B	654.0M	693.0M	609.0M	384.0M	439.0M	364.0M	140.0M	27.5M	31.0M	39.0M	23.0M	64.0M	35.0M	10.0M	7.0M
Dividends And Interest Paid	263.0M	176.0M	196.0M	188.0M	132.0M	97.5M	90.2M	77.1M	71.6M	44.3M	40.5M	50.3M	47.2M	105.0M	21.5M	50.2M	3.1M	855,000
Debt Repayments	536.0M	731.0M	838.0M	462.0M	798.0M	355.0M	408.0M	306.0M	246.0M	41.0M	30.5M	31.0M	43.0M	87.0M	35.0M	10.0M	11.0M	--
Total Financing Cash Inflow	1.1B	845.0M	1.1B	2.0B	848.0M	773.0M	398.0M	472.0M	634.0M	157.0M	49.7M	56.3M	62.0M	23.0M	1.1B	35.0M	65.6M	17.8M
Total Financing Cash Outflow	1.2B	1.0B	1.2B	752.0M	1.0B	680.0M	523.0M	398.0M	340.0M	109.0M	76.9M	83.1M	90.5M	196.0M	56.5M	60.2M	14.1M	855,000
Financing Cash Flow	-133.0M	-170.0M	-48.3M	1.3B	-170.0M	92.6M	-126.0M	74.6M	295.0M	47.7M	-27.2M	-26.9M	-28.5M	-173.0M	1.1B	-25.2M	51.6M	16.9M
Net Change In Cash	151.0M	-61.3M	-904.0M	1.0B	-24.5M	78.5M	-96.5M	126.0M	52.3M	-279.0M	-768,400	-292.0M	-196.0M	-286.0M	1.1B	3.6M	67.4M	19.2M
Ending Cash Balance	476.0M	325.0M	377.0M	1.3B	264.0M	289.0M	210.0M	307.0M	181.0M	128.0M	408.0M	408.0M	700.0M	896.0M	1.2B	118.0M	115.0M	47.4M
Capex	185.0M	252.0M	372.0M	306.0M	259.0M	230.0M	112.0M	109.0M	128.0M	151.0M	183.0M	252.0M	167.0M	185.0M	47.8M	31.3M	19.7M	17.0M